Abstract: The present invention relates to a composition for a gel polymer electrolyte, which includes a lithium salt, a non-aqueous organic solvent, a polymerization initiator, and an oligomer containing a polycarbonate-based repeating unit, a gel polymer electrolyte in which mechanical strength and ion transfer capability are improved by polymerization of the composition for a gel polymer electrolyte, and a lithium secondary battery in which external impact and stability during high-temperature storage are improved by including the gel polymer electrolyte.

Abstract: One aspect of the present disclosure is a pharmaceutical composition which includes (R)—N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of one aspect of the present disclosure has a formulation characteristic in which crystal formation is delayed for a long time.

Abstract: An electrolyte for a lithium secondary battery is disclosed herein. In some embodiments, an electrolyte includes a lithium salt present in a concentration of 1.6 M to 5 M, an oligomer mixture including a first oligomer containing a unit represented by Formula 1 and a second oligomer containing a unit represented by Formula 2, and an organic solvent.

Abstract: For collaboration between servers in an intelligent pharmacovigilance (PV) platform, a method of operating a server for providing a pharmacovigilance (PV) platform and managing a first database (DB) of a first member company and a second DB of a second member company may include obtaining information on an agreement between the first member company and the second company for a product, establishing a connection for data sharing between the first DB and the second DB, setting a rule for data sharing and performing control to share data related to the product between the first DB and the second DB based on the rule.

Abstract: A method of detecting safety information in an electronic document includes obtaining text data in the electronic document, performing preprocessing for transforming an abbreviation existing in the obtained text data in the electronic document into a full term, indexing or classifying text existing in the preprocessed electronic document, determining whether the electronic document is an individual case safety report (ICSR) using drug information and adverse event information, and outputting at least one report including at least one of a first result of determining a reference, a second result of indexing or classifying text or a third result of determining whether it is an ICSR. The at least one report includes at least one individual report including one of the first result, the second result or the third result, or at least one of integrated reports including a result of integrating a plurality of results among the first result, the second result and the third result.

Abstract: Disclosed herein are a method and apparatus for providing a pharmacovigilance (PV) platform, wherein a method for operating a server may include: receiving input data from a user device; generating at least one command set from the input data by using a first artificial intelligence model that is selected to process the input data; determining whether or not a user that provides the input data has an authority to execute the at least one command set; generating a result of a task, when the user has the authority, by using a second artificial intelligence model that is selected to perform the task according to the at least one command set; generating output data that displays the result of the task by using a visualization module that is selected to visualize the result of the task; and transmitting the output data to the user device.